Eckert & Ziegler: Shares from the capital increase authorised for trading (Prime Standard)

Eckert & Ziegler Strahlen- und Medizintechnik AG / Miscellaneous
21.12.2009 

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, 21.12.2009. The 1,350,000 shares issued in the course of the rights issue from authorised capital resolved in November 2009 and entered in the Commercial Register on December 10, 2009 were authorised for trading in the regulated market (Prime Standard) of the Frankfurt Stock Exchange with effect from December 21, 2009. The shares will be changed to the common ISIN DE0005659700 effective from December 22, 2009. The notification of the shares will take place also on December 22, 2009.

Eckert & Ziegler AG is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine and has approx. 520 employees. For the current year, the company expects sales of EUR 100 million and earnings per share of approx. EUR 1.80.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de, www.ezag.de




21.12.2009 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG               Robert-Rössle-Str.10
              13125 Berlin
              Deutschland
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700, DE000A0L1L69
WKN:          565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg  
End of News DGAP News-Service  

---